ANGELA GANGLOFF: Open Payments
NPI 1851056790 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,077 in 66 payments from 23 companies in 2025. Trend: 2023 $469 · 2024 $853 · 2025 $2,077
Food & beverage: $2,077
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 15 | $401 |
| Janssen Biotech, Inc. | 7 | $315 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $287 |
| IMMUNITYBIO, INC. | 2 | $186 |
| Novartis Pharmaceuticals Corporation | 3 | $104 |
| Janssen Pharmaceuticals, Inc | 4 | $104 |
| Astellas Pharma US Inc | 1 | $98 |
| PFIZER INC. | 4 | $95 |
| TOLMAR, INC. | 3 | $74 |
| Endo USA, Inc. | 2 | $53 |
Products named: GEMTESA, Nubeqa, RYBREVANT, Xtandi, ANKTIVA, ERLEADA, PLUVICTO, ORGOVYX.
Industry payments across MD — which companies pay providers there.
